Objective Ischemia-mediated oxidative stress and inflammation have been reported to be important contributors to the pathogenesis of polycystic ovary syndrome (PCOS). Ischemia-modified albumin (IMA) is a novel marker generated under ischemic and oxidative conditions and may reflect disease activity in distinct disease states. Therefore, we investigated whether the serum IMA levels are affected in infertile PCOS patients. Methods Forty-six patients with infertile PCOS, 30 patients with unexplained infertility, and 31 age-and body mass index (BMI)-matched controls were included in this cross-sectional study. Biochemical parameters, serum IMA levels, and their correlations with serum testosterone and insulin resistance were determined for each subject. Results In patients with infertile PCOS, the serum IMA levels were significantly elevated (p=0.003) compared with unexplained infertility patients and controls. A correlation analysis suggested that the IMA levels only correlated with the serum free testosterone levels in PCOS patients (r=0.43, p=0.028). Conclusion Elevations in the serum IMA levels in infertile PCOS patients may suggest a possible additional role of oxidative stress mechanisms in disease pathophysiology. Moreover, correlation between serum IMA and testosterone levels may influence the quality of oocytes via alterations in the balance of critical follicular fluid factors in the follicular microenvironment.
Introduction
Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility in women and affects an estimated of 10% of women of childbearing age (1) . It is an important cause of menstrual irregularities ranging from amenorrhea to menorrhagia, as well as androgen excess in women. PCOS is also considered to be an oxidative state, based on decreased antioxidant concentrations, reduced glutathione levels, as well as decreased levels of haptoglobin, a protein with antioxidant properties (2) (3) (4) . In addition to an association with increased cardiovascular risk due to atherosclerosis, diabetes mellitus, obesity, and metabolic syndrome, oxidative stress is also associated with failed reproductive performance, including infertility, miscarriage, preeclampsia, and diabetes-related congenital malformations (5) .
Increasing evidence suggests that reactive oxygen species (ROS) produced during tissue ischemia can generate the highly reactive hydroxyl radical. The production of this radical can result in N-terminal structural changes in albumin, especially at the N-Asp-Ala-His-Lys sequence, thereby generating ischemia-modified albumin (IMA) (6) . Although IMA was originally studied in patients with myocardial ischemia, it has been shown to be useful for evaluating patients with various disease conditions including ischemic events, type 2 diabetes mellitus, pulmonary embolism, liver cirrhosis, coronary bypass surgery, and metabolic syndrome (7) (8) (9) (10) (11) . Currently, IMA is regarded as a marker of oxidative stress and is also related to ischemia reperfusion in any body organ. In this context, data on IMA in PCOS patients have been obtained (12) , but no previous studies specifically address the role of IMA in infertile women with PCOS and unexplained infertility.
This study was performed in order to determine whether serum IMA levels are elevated in women with PCOS and unexplained infertility. Moreover, we also investigated the correlation between testosterone and insulin resistance with serum IMA in both PCOS patients and unexplained infertility patients.
Materials and Methods

Study design
Forty-six PCOS and 30 unexplained infertility patients that received IVF treatment in Dr. Zekai Tahir Burak Women's Health Education and Research Hospital Infertility Center, as well as 31 controls were enrolled in the present study. The study was reviewed and approved by the local ethics committee of the same hospital, and written informed consent was obtained from all patients.
Subjects
PCOS was defined based on clinical, laboratory, and ultrasound criteria according to the Rotterdam ESHRE/ ASRM-sponsored PCOS consensus workshop (13) . According to this consensus report, a diagnosis of PCOS was considered when at least two of the following criteria were fulfilled:
1. Oligoovulation or anovulation 2. Clinical and/or biochemical signs of hyperandrogenism 3. On ultrasonographic examination, the presence of polycystic ovaries Unexplained infertility patients recruited for this study were under the age of 40 years with normal ovulatory cycles. Patients also had normal baseline prolactin, folliclestimulating hormone (FSH), and thyroid-stimulating hormone levels; tubal patency at hysterosalpingography; normal transvaginal ultrasonography; and the presence of both normal ovaries.
Exclusion criteria included patients who had any history of endocrine or systemic disorders. Patients who had used oral contraceptive agents, antihyperlipidemic drugs, hypertensive medications, gonadotropin-releasing hormone agonists and antagonists, glucocorticoids, or antidiabetic drugs within the previous three months were also excluded.
The control group consisted of 31 healthy, age-and body mass index (BMI)-matched, normally ovulating women without any systemic disorders. None of the controls were hirsute, and all had regular menses every 21 to 35 days. All control subjects had normal ovaries in ultrasonographic examination and had normal luteinizing hormone (LH) and FSH levels.
For each patient, the weight and height were measured in light clothing without shoes. BMI was calculated according to the following formula: BMI = weight (kg) ÷ height (m 2 ).
IMA measurement
The cobalt to albumin binding capacity was analyzed using the rapid and colorimetric method defined by Bar-Or et al. (14) Briefly, 200 μL of patient serum were placed into glass tubes, and 50 μL of 0.1% CoCl2.6H2O (SigmaAldrich, St. Louis, USA) was added to the tubes. This mixture was incubated for 10 minutes to ensure sufficient cobalt-albumin binding. Afterwards, 50 μL of 1.5 mg/mL dithiothreitol (DTT) was added as a coloring agent, and the reaction was quenched 2 minutes later by adding 1.0 mL of 0.9% NaCl. Specimen absorbencies were analyzed at 470 nm by a spectrophotometer. The color of the DTTcontaining specimens was compared with that of the colorimetric control tubes. The results are expressed as absorbance units (ABSU). The intra-and interassay coefficients of variation were less than 3.1%.
Biochemical analyses
Blood samples were obtained without using any anticoagulant from a peripheral vein after an overnight fast (10-12 hours) with the participant in a seated position for 30 minutes. The tubes were centrifuged at 3,000 × g for 10 minutes and stored at -80°C until the analysis. As a routine diagnostic work-up, a blood chemistry test including fasting glucose, total cholesterol, triglycerides, FSH, LH, prolactin, insulin, free testosterone and estradiol was conducted on the day of sampling.
HOMA-IR calculation
Homeostatic model assessment of insulin resistance (HOMA-IR) was calculated according to the following formula: fasting insulin (μIU/mL) × fasting glucose (mg/dL)/ 405.
Statistical analyses
The Statistical Package for Social Sciences (version 18, SPSS Inc., Chicago, USA) for Windows was used to analyze the data. The variables were investigated using visual (histograms, probability plots) and analytical methods to determine whether they were normally distributed. Data are presented as mean ± standard deviation (SD) for normally distributed variables and as median ± (maximum -minimum) for skew-distributed continuous variables. Independent 
Results
The mean ages of the women in the PCOS, unexplained infertility, and control groups were 28.1±4.7, 29.7±4.8, and 31.3±6.3 years, respectively. Clinical and laboratory characteristics of patients in all groups are compared in Table 1 . Except for serum IMA, insulin, homeostatic model assessment values for insülin resistence (HOMA-IR), free testosterone, LH, and LH/FSH levels, clinical and laboratory parameters were comparable in all three groups. The median serum IMA levels of the PCOS, unexplained infertility, and control groups were 0.52 (0.21-1.12), 0.33 (0.06-0.99), and 0.35 (0.06-0.90) ABSU, respectively. Serum IMA levels of PCOS patients were significantly higher than those of the unexplained infertility and control groups (p=0.003) (Fig. 1) .
Although a significant correlation was observed between the serum free testosterone and IMA levels (r=0.43, p= 0.028) (Fig. 2) , no correlation was found between the serum IMA levels and other clinical and laboratory parameters (Table 2).
Discussion
In this cross-sectional study, we demonstrated that the serum IMA levels are elevated in infertile women with PCOS. The positive correlation between serum IMA and free testosterone levels in PCOS patients added support to the original hypothesis that IMA, as a reflection of oxidative stress in the follicular endocrine microenvironment, may be linked with impaired oocyte developmental competence and embryo quality in association with increased testosterone levels. During tissue ischemia, acidosis and superoxide free radical generation take place, and human serum albumin becomes unable to bind metal ions. IMA is produced as a result of this hypoxia, free radical injury, acidosis, ischemic conditions, and energy dependent membrane disruption that modify the N-terminal end of albumin (15, 16) . Although the definitive and exact pathophysiologic mechanism for this production is still unknown, current evidence suggests that it is associated with the generation of ROS, which modifies the metal binding domains of albumin (8, 17) .
The influence of oxidative stress on the IMA levels in PCOS have been investigated in several studies. In this respect, the study by Guven et al. (12) was the first to document the role of IMA in PCOS. They successfully demonstrated that serum IMA concentrations were elevated in patients with PCOS and that the levels were correlated with testosterone levels, BMI, and Ferriman Gallwey scores. A larger case-control study also documented significantly higher levels of IMA in young, lean PCOS patients, who closely resembled insulin-resistant patients (15) . These results were believed to indicate that chronic hypoxia and oxidative stress played significant roles in the metabolic consequences of PCOS. In contrast to both of these reports, Cakir et al. (18) reported no significant difference between PCOS patients and controls, albeit with an increasing trend in the PCOS group. In view of this discrepancy and to further our understanding of the role of IMA on oxidative stress cascades in infertile PCOS patients, we designed this crosssectional study to evaluate the exact role of IMA in infertile PCOS patients.
Women with PCOS seems to have a high prevelance of several comorbidities including obesity, hypertension, dyslipidemia, and diabetes mellitus (19) . Insulin resistence (IR) is a major characteristic feature of PCOS and now recognized to play a unique role in the pathogenesis and longterm sequelae of PCOS. Moreover, visceral obesity, which is believed to be a result of IR, is associated with increased incidence of diabetes mellitus and cardiovascular diseases in patients with PCOS (20) . For this reason, it has been suggested that PCOS should no longer be considered a purely gynaecological disorder, but rather a complex endocrine disorder. Although measuring IR with dynamic methods seems to be accurate but inconvenient for clinical practice in PCOS patients, HOMA-IR can be used as a surrogate measure of IR. In this context, elevated HOMA-IR scores in PCOS patients have been described in a number of studies (21) (22) (23) (24) . In one of the largest of these studies, which included 271 PCOS patients, the prevelance of IR was found to be 64% according to the HOMA-IR measurement (21) . Similarly, in a recent study by Macut et al. (22) , indices of insulin resistance (insulin and HOMA-IR) were found to be significantly elevated in PCOS patients and positively correlated with levels of oxidative stress markers. These positive correlations between IR, hyperinsulinemia, and oxidative stress are likely to accelerate the development of cardiovascular disease in patients with PCOS. In our study HOMA-IR was found to be elevated in PCOS patients compared to the unexplained infertility and healthy control groups. However, we could not determine any significant difference between the study groups in terms of the serum glucose levels.
The role of IMA in distinct disease states has been a subject of intense research and controversy. Recent studies have demonstrated that significantly higher IMA levels are found in patients with cardiac ischemia, metabolic syndrome, hyperlipidemia, and diabetes mellitus (7-10). Moreover, Ertekin et al. (25) investigated the diagnostic value of IMA levels in patients with acute coronary syndrome and ischemic stroke symptoms and concluded that IMA could be a useful diagnostic marker in acute coronary syndrome and ischemic stroke. In a large series of breast cancer patients, IMA was regarded as a potential novel marker for diagnosing doxorubicin-induced myocardial injury by predicting long-term impairment of cardiac function (26) . In contrast, however, Kim et al. (27) reported that IMA levels did not differ between patients with nonischemic chest pain and ischemic chest pain. Those authors therefore proposed that, in clinical practice, assessment of serum IMA levels for triage of patients with acute chest pain does not seem to be useful. Based on this evidence, IMA can be regarded as a non-specific marker and could be elevated in subjects undergoing oxidative stress due to various clinical conditions.
We recognize some limitations of our study that we must take into consideration. First, if we had analyzed other oxidative stress parameters, including nitric oxide, total oxidant status, and total antioxidant status, we might have been able to suggest a possible mechanism depicting the role of IMA on PCOS pathophysiology. Second, a variety of physiological factors can affect the levels of IMA in the body. For example, short-term postprandial IMA elevation was demonstrated in an elegant study by Bhagavan et al. (28) Despite growing evidence that supports a significant alteration of serum IMA levels during exercise in coronary artery disease patients (29) , in a study of marathon runners (30) , the serum IMA levels did not increase immediately after a marathon run, indicating that skeletal muscle ischemia during exercise does not affect serum IMA concentrations. Finally, although there is little information on diurnal variation in serum levels of IMA, Dominguez-Rodriguez et al. (31) demonstrated a diurnal fluctuation with significantly higher levels at 02.00 h in ST-elevation myocardial infarction patients and no serum IMA diurnal variations in healthy subjects.
In conclusion, this study has demonstrated that the serum IMA levels were significantly elevated in PCOS patients compared with the unexplained infertility group and healthy controls of similar age and BMI.
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